Where does Biogen Idec MA Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biogen Idec MA Inc. ranks #20,831 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biogen Idec MA Inc. hold?

Biogen Idec MA Inc. holds 13 US utility patents granted between 2015 and 2017, spanning 14 technology areas.

What is Biogen Idec MA Inc.'s Innovation Score?

Biogen Idec MA Inc. has an Innovation Score of 36.2 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biogen Idec MA Inc. focus on?

Biogen Idec MA Inc.'s top technology area is C07K (Peptides) with 11 patents, ranking #825 of 3,615 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Biogen Idec MA Inc.'s patent grant rate increasing or decreasing?

Biogen Idec MA Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biogen Idec MA Inc.'s patents?

Biogen Idec MA Inc.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biogen Idec MA Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biogen Idec MA Inc.

USPTO PatentsView assignee record - 13 granted patents across 14 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biogen ranks #20,831 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 14 technology areas.

#20,831
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.2/100): 23.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20831 · US Corporation #20,831 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,831/49,997
PHOTO-FINISH Billie
CPC-FOCUS C07K · 14 areas
INNOV-THIN 36.2/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Billie, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biogen’s 36.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (25%) Velocity 0.0 pts (0%) Breadth 13.2 pts (37%) Claim depth 13.8 pts (38%)

Qualcomm Incorporated · highest

85
Biogen Idec MA · this assignee

36
3D Lighting… · lowest

7

What this shows Biogen's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biogen?

Each dot is one of Biogen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biogen’s own 23.1 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biogen's grants concentrate

Biogen Idec MA Inc. is a focused PatentsView assignee: 14 CPC subclasses with 84.6% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (11 grants) versus a trough of 1 in 2016. By volume, Biogen sits between Billie, Inc. and Black & Veatch Corporation.

Billie

13
Bioelectron Techn…

13
Biofreeze IP Hold…

13
Biogen Chesapeake

13
Bioniz

13
Bitanimate

13
Bizlink Industry…

13
Black & Veatch

13
Biogen Idec MA ◀

13

What this shows Biogen holds 13 patents at rank #20,818, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biogen

By rank, the assignees closest to #20,818 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Biogen's primary technology class.

Biogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biogen Idec MA Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	84.6%
2016	1	7.7%
2017	1	7.7%

Which technologies does Biogen Idec MA Inc. patent most?

C07K - Peptides 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

C07D - Heterocyclic Compounds 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Y10T - Technical Subjects Covered BY Former US Classification 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biogen Idec MA Inc.'s patent record in context - here's where to go next.

Biogen Idec MA Inc.'s lead technology class is C07K (Peptides), 84.6% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #20,831 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biogen Idec MA Inc. against Billie, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.